RT Journal Article SR Electronic T1 TMPRSS2 variants and their susceptibility to COVID-19: focus in East Asian and European populations JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.09.20126680 DO 10.1101/2020.06.09.20126680 A1 Ney Pereira Carneiro dos Santos A1 André Salim Khayat A1 Juliana Carla Gomes Rodrigues A1 Pablo Pinto A1 Gilderlanio Santana de Araújo A1 Lucas Favacho Pastana A1 Jéssyca Amanda Gomes Medeiros A1 Marianne Rodrigues Fernandes A1 Arthur Ribeiro-dos-Santos A1 Bruna Claudia Meireles Khayat A1 Fabiano Cordeiro Moreira A1 André Maurício Ribeiro-dos-Santos A1 Paula Baraúna de Assumpção A1 Ândrea Ribeiro-dos-Santos A1 Paulo Pimentel de Assumpção A1 Sidney Santos YR 2020 UL http://medrxiv.org/content/early/2020/06/11/2020.06.09.20126680.abstract AB The manifestation of the COVID-19 varies from absence of symptoms to Severe Acute Respiratory Syndrome. The epidemiological data indicate that infection and mortality rates are greater in European populations in comparison with eastern Asians. To test if epidemiological patterns may be partly determined by human genetic variation, we investigated, by exomic and databank analyses, the variability found in the TMPRSS2 gene in populations from different continents, since this gene is fundamental to virus access into human cells. The functional variants revealed low diversity. The analyses of the variation in the modifiers of gene expression indicate that the European populations may have much higher levels of pulmonary expression of the TMPRSS2 gene and would be more vulnerable to infection by SARS-CoV-2. By contrast, the pulmonary expression of the TMPRSS2 may be reduced in the populations from East Asia, which implies that they are less susceptible to the virus infection and, these genetic features might also favor their better outcomes. The presented data, if confirmed, indicates a potential genetic contribution of TMPRSS2 to individual susceptibility to viral infection, and might also influence COVID-19 outcome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank CNPq, CAPES, FAPESPA, UFPA (PROPESP). This work is part of RPGPH (Biocomputacional, Protocol No. 3381/2013/CAPES), Universal (Protocolo No. 431488/2016-9/CNPq); and FAPESPA - Fundacao Amazonia. We highlight that: S.E.B.S. is supported by CNPq/Produtividade (305496/2017-4); A.R.S. is supported by CNPq/Produtividade (306815/2018-4).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present study was approved by the Brazilian National Committee for Ethics in Research (CONEP) and the Research Ethics Committee of the UFPA Tropical Medicine Center, under CAAE number 20654313.6.0000.5172. All the participants, together with the tribal leaders, signed a free informed-consent form, and whenever necessary, a translator explained the project and its importance to the participants. The participants were recruited between September 2017 and December 2018.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes- The 1,000 Genomes Project (available at http://www.1000genomes.org) - Online Archive of Brazilian Mutations (ABraOM) (available at http://abraom.ib.usp.br). http://www.1000genomes.org http://abraom.ib.usp.br